A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded by the Horizon 2020 programme (847989) has published the firs...
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet...
A study by the Clínic-IDIBAPS shows that silencing this gene reduces the growth of liver cancer in mice. The research, using different animal model...
Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to condu...
The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow li...
Researchers from the Hospital Clínic-IDIBAPS have published a review in Nature Reviews Clinical Oncology about the adjuvant and neoadjuvant treatme...
Endowed with €12 million, the project is coordinated by Prof. Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Onco...
The IDIBAPS Board of Trustees has approved the creation of a new research group. The decision results from a scientific evaluation by the ad hoc co...
IDIBAPS researchers have reviewed the role of fibroblasts, a type of cell found in the liver, in the progression of liver cancer, both hepatocellul...
Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the sec...
